UVA Health researchers are advancing a technology that may allow new vaccines to be designed, tested and distributed in weeks ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...

SK Bioscience has joined a new international effort to advance an updated Zaire ebolavirus vaccine, following a funding agreement between the CEPI and Merck & Co.

Jan 21 (Reuters) - Merck and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., ...

AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...